Enabling Affordable Gene Therapies Through Continuous Viral Vector Manufacturing

Name: Enabling Affordable Gene Therapies Through Continuous Viral Vector Manufacturing
Start: 2026-11-12T14:55
End: 2026-11-12T15:15
Location: Novotel London West

Cell 2026 · 12 November 2026 · 14:55–15:15 · Conference Room 2

Enabling Affordable Gene Therapies Through Continuous Viral Vector Manufacturing was a session at Cell 2026 on 12 November 2026 in London, with 1 speaker on record.

Speakers

Chloe Hurling — Speaker Associate Senior Bioprocessing Scientist, Cell & Gene Therapy Catapult